{"cik":"0001652130","ticker":"NTLA","name":"Intellia Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-04-27","last_filing_date":"2026-04-27","url":"/sec/cik-0001652130","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-179401","form_type":"8-K","form_type_family":"current","doc_date":"2026-04-27","title":"8-K — Intellia Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001652130/8-k/0001193125-26-179401","edgar_url":"https://www.sec.gov/Archives/edgar/data/1652130/0001193125-26-179401-index.html"},{"accession_number":"0001193125-26-182419","form_type":"424B5","form_type_family":"registration","doc_date":"2026-04-27","title":"424B5 — Intellia Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001652130/424b5/0001193125-26-182419","edgar_url":"https://www.sec.gov/Archives/edgar/data/1652130/0001193125-26-182419-index.html"}],"related_endpoints":{"profile":"/sec/NTLA/profile","timeline":"/sec/NTLA/timeline","peers":"/sec/NTLA/peers","insider_pulse":"/sec/NTLA/insider-pulse","insider_summary":"/sec/NTLA/insider-summary","insider_transactions":"/sec/NTLA/insider-transactions","form144":"/sec/NTLA/form144","holdings_as_filer":"/sec/NTLA/holdings","financial_facts":"/sec/NTLA/financial-facts","derivatives":"/sec/NTLA/derivatives","officers":"/sec/NTLA/officers","insider_network":"/sec/NTLA/insider-network","risk_flags":"/sec/NTLA/risk-flags","filings":"/sec/NTLA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=NTLA"}}